Evidence map›Paper›PMID 38893535›Full record

ArticleMolecules (Basel, Switzerland)2024

Substitution-Induced Mechanistic Switching in S

Collin Zimmer, Jan Brauer, Dorota Ferenc, Jessica Meyr, Patrick Müller, Hans-Joachim Räder, Bernd Engels, Till Opatz, Tanja Schirmeister

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. RSC chemical biology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Collin ZimmerInstitute of Pharmaceutical and Biomedical Sciences, University of Mainz, Staudingerweg 5, 55128 Mainz, Germany.ORCID 0000-0002-3826-9369
Jan BrauerDepartment of Chemistry, University of Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.ORCID 0000-0001-7094-534X
Dorota FerencDepartment of Chemistry, University of Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
Jessica MeyrInstitute of Physical and Theoretical Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074 Würzburg, Germany.ORCID 0000-0003-0422-870X
Patrick MüllerInstitute of Pharmaceutical and Biomedical Sciences, University of Mainz, Staudingerweg 5, 55128 Mainz, Germany.ORCID 0000-0003-1283-9025
Hans-Joachim RäderMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
Bernd EngelsInstitute of Physical and Theoretical Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074 Würzburg, Germany.ORCID 0000-0003-3057-389X
Till OpatzDepartment of Chemistry, University of Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.ORCID 0000-0002-3266-4050
Tanja SchirmeisterInstitute of Pharmaceutical and Biomedical Sciences, University of Mainz, Staudingerweg 5, 55128 Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the transition from non-covalent reversible over covalent reversible to covalent irreversible inhibition of cysteine proteases by making delicate structural changes to the warhead scaffold. To this end, dipeptidic rhodesain inhibitors with different

Indexed as

Cysteine ProteasesCysteine Proteinase InhibitorsMolecular Docking SimulationCysteine EndopeptidasesMolecular StructureStructure-Activity RelationshipCysteine EndopeptidasesCysteine ProteasesCysteine Proteinase Inhibitorsrhodesaincovalencyelectrophilic warheadpermeabilityreversibilityrhodesainSNAr

Identifiers

PMID38893535
PMCPMC11173422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.